• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management

Sneak Peek: 2024 Fall Clinical Dermatology Conference for PAs and NPs

News
Article

Dermatology Times will bring clinical insights from leading experts in numerous dermatology specialties.

Diverse crowd sitting in conference seminar | Image Credit: © borisblik - Adobe Stock

Image Credit: © borisblik - Adobe Stock

The 2024 Fall Clinical Dermatology Conference for PAs and NPs kicks off this weekend in Scottsdale, Arizona. Dermatology Times will be on-site bringing clinical insights from leading experts in numerous dermatology treatment specialties presenting to physician assistants and nurse practitioners from around the country.

Dermatology Times will feature interviews throughout the weekend from leaders in dermatology including:

  • Terry Arnold, PA-C, vice president of medical affairs at DermTech, Inc., who will present the sessions “What Else Can I Do With My Medical Training?” and “So You Want to Work in the Pharma Industry?”
  • Raj Chovatiya, MD, PhD, associate professor at the Rosalind Franklin University Chicago Medical School, founder and director of the Center for Medical Dermatology and Immunology Research, and Dermatology Times’ Fall 2024 Editor in Chief, who will present the sessions “How Seb D Got Its Groove Back” and “Talking JAK: Patient Conversations and Best Practices”
  • Jason Hawkes, MD, MS, dermatologist with the International Psoriasis Council, who will present the sessions “What's New in Generalized Pustular Psoriasis?” and “Mechanism of Action of JAKs”
  • Benjamin Lockshin, MD, assistant professor of dermatology at Georgetown University Hospital, who will present the session “Oral Options for Psoriasis Therapies”
  • E. James Song, MD, director of clinical research at Frontier Dermatology Partners, who will present the sessions “What's New in Alopecia Areata,” “Deciphering AD Therapy Options,” and “Combining Systemics in AD and Psoriasis Therapies

Organizers have planned for the annual conference to provide maximum engagement and value to attendees both in-person and online for some sessions. Stay up-to-date with all conference coverage and new pearls to put into practice from Dermatology Times by subscribing to our email newsletters and following us on Facebook, LinkedIn, and X.

Earlier this week, Dermatology Times published a poll asking what content from the 2024 Fall Clinical Dermatology Conference for PAs and NPs you want to learn and the results are:

  • 28% of respondents said pathogenesis and management of psoriasis, atopic dermatitis, and acne vulgaris
  • 42% of respondents said up-to-date information on safe and effective use of biologic agents
  • 2% of respondents said enhanced knowledge of skin cancer prevention, diagnosis, and management
  • 14% of respondents said incorporating new techniques and uses of dermal fillers and neurotoxins
  • 14% of respondents said other

Learning Objectives

Organizers for the 2024 Fall Clinical Dermatology Conference for PAs and NPs have outlined 8 key learning objectives. They say attendees will be better equipped to:

1. Discuss the pathogenesis and optimal management of psoriasis, atopic dermatitis, and acne vulgaris: Attendees will delve into the underlying mechanisms and best treatment practices for these common dermatologic conditions, gaining a deeper understanding that will aid in more effective patient management.

2. Update knowledge regarding recent advances in the safe and effective use of biologic agents for the treatment of dermatologic diseases: With biologics becoming increasingly pivotal in dermatologic care, this objective ensures that practitioners stay abreast of the latest advancements and safety protocols.

3. Enhance the ability to evaluate and incorporate new techniques and uses of dermal fillers and neurotoxins: The conference will cover the latest trends and techniques in cosmetic dermatology, enabling attendees to enhance their aesthetic practice with cutting-edge skills.

4. Identify and describe the indications, contraindications, and evidence-based safety and efficacy profiles of new agents approved for use in the dermatology setting: Participants will receive comprehensive updates on newly approved dermatologic agents, backed by evidence-based safety and efficacy data.

5. Integrate prevention, diagnosis, and management of skin cancer into a clinical setting: Given the rising incidence of skin cancer, this objective emphasizes the importance of integrating robust prevention, diagnostic, and management strategies into clinical practice.

6. Diagnose commonly presented dermatologic disorders: Attendees will refine their diagnostic skills, ensuring they are well-equipped to identify and manage a broad spectrum of dermatologic conditions.

7. Improve my clinical interactions with patients: Effective patient communication is crucial in dermatology. This objective aims to enhance practitioners' abilities to interact empathetically and effectively with their patients.

8. Integrate knowledge to enhance daily dermatologic care: The conference will provide actionable insights that practitioners can immediately apply to elevate the quality of care they provide daily.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.